July 17 Financial Quick Takes: Chipscreen's Shanghai listing advances; plus Avrobio, Repligen and Seer

Chipscreen clears hurdle for Shanghai IPO

With registration of its application by China Securities Regulatory Commission, Shenzhen Chipscreen Biosciences Ltd. (Shenzhen, China) overcame the final hurdle for its proposed listing on Shanghai’s science and technology innovation board, also known as the STAR market. Chipscreen is the first biotech to complete the required registration process for the market, which is expected to see its first batch of companies debut on Monday. A listing date has yet to be set on the exchange, which approved Chipscreen's application last month (See "Chipscreen Set to Test Shanghai’s New Innovation Board")...